163 related articles for article (PubMed ID: 7439279)
21. Surgery, BCG immunotherapy, and multichemotherapy in T3 stage-3 bronchogenic carcinoma.
Rioseco A
Chest; 1981 Feb; 79(2):176-85. PubMed ID: 7460649
[TBL] [Abstract][Full Text] [Related]
22. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma.
Freitag L; Ernst A; Thomas M; Prenzel R; Wahlers B; Macha HN
Thorax; 2004 Sep; 59(9):790-3. PubMed ID: 15333857
[TBL] [Abstract][Full Text] [Related]
23. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
[TBL] [Abstract][Full Text] [Related]
24. Further studies on the serological effects of C. parvum immunotherapy in cancer patients.
James K; Merriman J; Woodruff MF; McCormick JN; McBride WH; Innes J; Horne NW
Dev Biol Stand; 1977 Apr 13-15; 38():501-6. PubMed ID: 608542
[TBL] [Abstract][Full Text] [Related]
25. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
Järvinen R; Kaasinen E; Sankila A; Rintala E;
Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy in bronchogenic carcinoma.
Takita H; Brugarolas A
Surg Forum; 1972; 23(0):98-9. PubMed ID: 4671038
[No Abstract] [Full Text] [Related]
27. Bcg and autoimmunity: another two-edged sword.
Shoenfeld Y; Aron-Maor A; Tanai A; Ehrenfeld M
J Autoimmun; 2001 May; 16(3):235-40. PubMed ID: 11334488
[TBL] [Abstract][Full Text] [Related]
28. [Results of the treatment of papilloma and bronchogenic carcinoma with interferon alpha].
Szklarz E
Pol Tyg Lek; 1990 Aug 6-13; 45(32-33):669-72. PubMed ID: 2077510
[TBL] [Abstract][Full Text] [Related]
29. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.
Yanagawa E; Yasumoto K; Manabe H; Nagano N; Hirota N; Ohta M; Hattori T; Nomoto K; Azuma I; Yamamura Y
Gan; 1979 Aug; 70(4):533-9. PubMed ID: 229054
[TBL] [Abstract][Full Text] [Related]
30. Transbronchial needle aspiration (TBNA) in the early diagnosis and staging of bronchogenic carcinoma.
Chokhani R; Gasparini S
Indian J Chest Dis Allied Sci; 2003; 45(2):111-5. PubMed ID: 12715933
[TBL] [Abstract][Full Text] [Related]
31. [Polyarthritis in 4 patients treated with intravesical BCG-therapy for carcinoma of the bladder].
Belmatoug N; Levy-Djebbour S; Appelboom T; De Gennes C; Peltier AP; Meyer O; Kahn MF; Carbon C
Rev Rhum Ed Fr; 1993 Feb; 60(2):162-6. PubMed ID: 8136810
[TBL] [Abstract][Full Text] [Related]
32. Advances in bronchoscopy.
Marsh BR
Otolaryngol Clin North Am; 1978 Jun; 11(2):371-88. PubMed ID: 693043
[No Abstract] [Full Text] [Related]
33. [Stimulating immunity with the use of Corynebacterium parvum after resection of carcinoma of bronchial origin. Clinical aspects].
Dangubić V; Dujić A; Lilić D; Kolasinović N; Jeremić K
Srp Arh Celok Lek; 1982 Sep; 110(9):1017-24. PubMed ID: 7182936
[No Abstract] [Full Text] [Related]
34. BCG, levamisole and transfer factor in the treatment of cancer.
Spitler LE
Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
[No Abstract] [Full Text] [Related]
35. [The immunostate and immunotherapy of primary bronchogenic carcinoma (author's transl)].
Deng WW
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(1):56-8. PubMed ID: 551912
[No Abstract] [Full Text] [Related]
36. Cellular immune reactions in patients with bronchogenic carcinoma before and after radio-, chemo- and immunotherapy.
Gropp C; Havemann K
Z Immunitatsforsch Immunobiol; 1977 Sep; 153(3):236-47. PubMed ID: 930234
[No Abstract] [Full Text] [Related]
37. Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy.
Gonzalez OY; Musher DM; Brar I; Furgeson S; Boktour MR; Septimus EJ; Hamill RJ; Graviss EA
Clin Infect Dis; 2003 Jan; 36(2):140-8. PubMed ID: 12522745
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant immunotherapy for bronchogenic carcinoma: preliminary results.
Takita H; Brugarolas A
Cancer Chemother Rep 3; 1973 Mar; 4(2):293-8. PubMed ID: 4729333
[No Abstract] [Full Text] [Related]
39. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y
Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy of superficial bladder tumors: preliminary results with ImmuCyst--BCG Connaught, Toronto.
Hanus M; Matousková M; Verner P; Hyrsl L
Neoplasma; 1994; 41(1):25-7. PubMed ID: 8202191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
